Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations

OBJECTIVE: To investigate the efficacy of tyrosine kinase inhibitors (TKIs) in the treatment of metastatic renal cell carcinoma (mRCC) with rhabdoid (mRCC‐R) and sarcomatoid (mRCC‐S) differentiations. MATERIALS AND METHODS: In this single‐institutional cohort study, we included patients with RCC wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kun, Duan, Pengqiang, Chen, Xusheng, Yang, Qing, Feng, Guowei, Diao, Lei, Zhang, Zhenting, Yao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358213/
https://www.ncbi.nlm.nih.gov/pubmed/37325945
http://dx.doi.org/10.1002/cam4.6081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358213/
https://www.ncbi.nlm.nih.gov/pubmed/37325945
http://dx.doi.org/10.1002/cam4.6081

Ejemplares similares